Artificial Inteligence Used in Drug Discovery

The traditional drug discovery process is time consuming, costly and often yields limited success. Recent advancements in artificial intelligence (AI) have transformed the landscape of drug discovery, enabling faster, more accurate, and cost-effective identification of potential therapeutic candidates. AI powered approaches, such as machine learning (ML) and deep learning (DL), are being employed to analyze vast amounts of biological and chemical data, predict molecular interactions, and optimize lead compounds. This abstract review the current state of AI in drug discovery, highlighting its applications in target identification, compound screening, and lead optimization. We also discuss the challenges and future directions of AI driven drug discovery, emphasizing the potential for AI to revolutionize the development of novel therapeutics.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-03-03
DOI
https://doi.org/10.5281/zenodo.14961714
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Artificial Inteligence Used in Drug Discovery

Zenodo (CERN European Organization for Nuclear Research)
Computational Drug Discovery Methods
article

Artificial Inteligence Used in Drug Discovery

article en

Abstract

The traditional drug discovery process is time consuming, costly and often yields limited success. Recent advancements in artificial intelligence (AI) have transformed the landscape of drug discovery, enabling faster, more accurate, and cost-effective identification of potential therapeutic candidates. AI powered approaches, such as machine learning (ML) and deep learning (DL), are being employed to analyze vast amounts of biological and chemical data, predict molecular interactions, and optimize lead compounds. This abstract review the current state of AI in drug discovery, highlighting its applications in target identification, compound screening, and lead optimization. We also discuss the challenges and future directions of AI driven drug discovery, emphasizing the potential for AI to revolutionize the development of novel therapeutics.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 49%
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.